Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000252704 | SCV000318204 | benign | Cardiovascular phenotype | 2013-01-22 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000389278 | SCV000339926 | likely benign | not specified | 2016-03-02 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000468607 | SCV000555536 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001707605 | SCV000726320 | likely benign | not provided | 2020-08-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001840445 | SCV002100738 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2J | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001840446 | SCV002100739 | benign | Myopathy, myofibrillar, 9, with early respiratory failure | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001840447 | SCV002100740 | benign | Early-onset myopathy with fatal cardiomyopathy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001840444 | SCV002100742 | benign | Tibial muscular dystrophy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000389278 | SCV004813374 | likely benign | not specified | 2024-02-19 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000389278 | SCV001978883 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001707605 | SCV001980620 | likely benign | not provided | no assertion criteria provided | clinical testing |